Wednesday, 09th July
Register
Log in
Conditions & Disease
Alzheimer’s & Dementia
COVID-19
Cancer
Heart & Lung
Diabetes
Infection/Disease
Disciplines & Care
Dentistry
ENT
Vision
Men's Health
Women's Health
Muscular & Skeletal
Nursing & Care
Paediatrics
Psychology
Reproductive Health
Surgery
Genetics
Health & Wellness
Addiction
Aesthetic
All Creatures
Lifestyle
All Creatures
Mental Health
Lifestyle
NHS
Welfare & Policy
Nutrition
Neurodiversity
Sexual Health
News & Research
Australasia
CPD
Global Reach
Innovation
Medico-Legal
Pharmacy/Drugs
Biotech
Environment
Unsung Heroes
Karen Aiach
About
Latest Posts
Karen Aiach
Karen Aiach is CEO and founder of Lysogene, a biotech company developing gene therapy for central nervous system disorders.
Latest posts by Karen Aiach
(
see all
)
Gene therapy for nervous system disorders
- 16th April 2017
Gene therapy for nervous system disorders
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
